Ladenburg Thalmann Reiterates Buy on TG Therapeutics, Maintains $39 Price Target

Moomoo 24/7 ·  Apr 18 13:27

Ladenburg Thalmann analyst Matthew Kaplan reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $39 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment